Status:
ENROLLING_BY_INVITATION
Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes
Lead Sponsor:
Erasme University Hospital
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the impact of the DBLG1 hybrid closed-loop system on glycemic control and patient-reported outcomes in adults living with type 1 diabetes under real-life conditions.
Detailed Description
This is a multicenter real-world observational study analyzing data on the use of the DBLG1 system in patients with T1D treated in the participating centers in Belgium. Data from patients with T1D who...
Eligibility Criteria
Inclusion
- patients with type 1 diabetes
- aged 18 years and older
- starting with the DBLG1 system in the participating centers
- who signed the informed consent
Exclusion
- patients who do not have type 1 diabetes
- younger than 18 years
- who do not start with the DBLG1 system
- who are not able to sign the informed consent
- who do not want to sign the informed consent
Key Trial Info
Start Date :
December 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT06154135
Start Date
December 30 2022
End Date
July 30 2026
Last Update
December 12 2023
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, OLVZ Aalst
Aalst, Belgium, 9300
2
Department of Endocrinology, Imeldaziekenhuis
Bonheiden, Belgium, 2820
3
Department of Endocrinology, ULB-Hôpital Erasme
Brussels, Belgium, 1070
4
Department of Endocrinology and Nutrition, Cliniques Universitaires St. Luc
Brussels, Belgium, 1200